Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,443
Closed -$535K 1903
2026
Q1
$535K Buy
+6,443
New +$552K ﹤0.01% 809
2025
Q3
Sell
-6,367
Closed -$645K 1229
2025
Q2
$645K Buy
+6,367
New +$649K 0.01% 837
2024
Q4
Sell
-1,840
Closed -$266K 1809
2024
Q3
$266K Sell
1,840
-263
-13% -$35.9K 0.01% 1652
2024
Q2
$307K Buy
+2,103
New +$295K 0.01% 1454
2024
Q1
Sell
-11,930
Closed -$1.11M 1854
2023
Q4
$1.11M Buy
11,930
+5,710
+92% +$527K 0.03% 569
2023
Q3
$549K Sell
6,220
-40,491
-87% -$4.16M 0.01% 921
2023
Q2
$5.25M Buy
+46,711
New +$5.57M 0.12% 163
2022
Q1
Sell
-17,710
Closed -$2.27M 1651
2021
Q4
$2.27M Buy
17,710
+13,042
+279% +$2.01M 0.05% 335
2021
Q3
$669K Buy
4,668
+2,592
+125% +$356K 0.04% 509
2021
Q2
$242K Sell
2,076
-1,485
-42% -$146K 0.01% 1114
2021
Q1
$286K Sell
3,561
-3,397
-49% -$259K 0.01% 814
2020
Q4
$436K Buy
+6,958
New +$397K 0.02% 498

Other funds holding CROX

Centiva Capital's CROX Position: Q2 2026 in Review

Centiva Capital sold out of Crocs (CROX) in Q2 2026, closing a stake of 6,443 shares — an estimated $535K sold.

Centiva Capital first reported a position in CROX in Q4 2020 and held it in 12 quarters. The position peaked at $5.25M in Q2 2023. 501 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Centiva Capital reported no remaining Crocs position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 6,443 Crocs shares in Q2 2026, an estimated $535K.
  • Centiva Capital first reported a position in Crocs in Q4 2020 and held it in 12 quarters.
  • Centiva Capital's Crocs position peaked at $5.25M in Q2 2023.
  • 501 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.